Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Carolyn Rydyznski Moderbacher"'
Autor:
Carolyn Rydyznski Moderbacher, Christina Kim, Jose Mateus, Joyce Plested, Mingzhu Zhu, Shane Cloney-Clark, Daniela Weiskopf, Alessandro Sette, Louis Fries, Gregory Glenn, Shane Crotty
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 19 (2022)
NVX-CoV2373 is an adjuvanted recombinant full-length SARS-CoV-2 spike trimer protein vaccine demonstrated to be protective against COVID-19 in efficacy trials. Here we demonstrate that vaccinated individuals made CD4+ T cell responses after 1 and 2 d
Externí odkaz:
https://doaj.org/article/d1bcb00519ff408b99a843d3d67b9a38
Autor:
Zeli Zhang, Jose Mateus, Camila H. Coelho, Jennifer M. Dan, Carolyn Rydyznski Moderbacher, Rosa Isela Gálvez, Fernanda H. Cortes, Alba Grifoni, Alison Tarke, James Chang, E. Alexandar Escarrega, Christina Kim, Benjamin Goodwin, Nathaniel I. Bloom, April Frazier, Daniela Weiskopf, Alessandro Sette, Shane Crotty
Publikováno v:
bioRxiv
SUMMARYMultiple COVID-19 vaccines, representing diverse vaccine platforms, successfully protect against symptomatic COVID-19 cases and deaths. Head-to-head comparisons of T cell, B cell, and antibody responses to diverse vaccines in humans are likely
Autor:
Jennifer M. Dan, Shane Crotty, Zeli Zhang, Benjamin Goodwin, Alessandro Sette, Daniela Weiskopf, Carolyn Rydyznski Moderbacher, Jose Mateus, Marshall Lammers
Publikováno v:
Science (New York, N.Y.)
A smaller-dose jab does the job Low-dose messenger RNA (mRNA) vaccines potentially allow health providers to administer more doses from a limited vaccine supply and can be less reactogenic. Whether low-dose COVID-19 mRNA vaccines generate immune resp
Autor:
Benjamin Goodwin, Jose Mateus, Jennifer M. Dan, Marshall Lammers, Zeli Zhang, Carolyn Rydyznski Moderbacher, Alessandro Sette, Shane Crotty, Daniela Weiskopf
Understanding human immune responses to SARS-CoV-2 RNA vaccines is of interest for a panoply of reasons. Here we examined vaccine-specific CD4+ T cell, CD8+ T cell, binding antibody, and neutralizing antibody responses to the 25 μg Moderna mRNA-1273
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c7b8ec852aeb49d75f6eb9eefdd6b5f
https://doi.org/10.1101/2021.06.30.21259787
https://doi.org/10.1101/2021.06.30.21259787
Autor:
Simon Bélanger, Cheryl Kim, Robert K. Abbott, Kathryn M. Hastie, Sydney I. Ramirez, Alessandro Sette, Jennifer M. Dan, April Frazier, Yu Kato, Davey M. Smith, Longping V. Tse, Eleanor G. Crotty, Ralph S. Baric, Stephen A. Rawlings, Erica Ollmann Saphire, Jason A. Greenbaum, Shane Crotty, Daniela Weiskopf, Bjoern Peters, Christina K. Kim, Alba Grifoni, Carolyn Rydyznski Moderbacher, Jose Mateus, Jinyong Choi
Publikováno v:
Cell
Cell, vol 183, iss 4
Cell, vol 183, iss 4
Limited knowledge is available on the relationship between antigen-specific immune responses and COVID-19 disease severity. We completed a combined examination of all three branches of adaptive immunity at the level of SARS-CoV-2-specific CD4+ and CD
Autor:
Florian Krammer, April Frazier, Aaron F. Carlin, Alessandro Sette, Jennifer M. Dan, Bjoern Peters, Davey M. Smith, Alba Grifoni, Shane Crotty, Aravinda M. de Silva, Jason A. Greenbaum, Jose Mateus, Daniela Weiskopf, Lakshmanane Premkumar, Daniel Marrama, Aaron Sutherland, Ramesh Jadi, Carolyn Rydyznski Moderbacher, Sydney I. Ramirez, Stephen A. Rawlings
Publikováno v:
Cell
Cell, vol 181, iss 7
Cell, vol 181, iss 7
Summary Understanding adaptive immunity to SARS-CoV-2 is important for vaccine development, interpreting coronavirus disease 2019 (COVID-19) pathogenesis, and calibration of pandemic control measures. Using HLA class I and II predicted peptide ‘meg